Posted: October 21, 2009

Carl Zeiss Introduces Barrier-Breaking Superresolution Microscope Systems

(Nanowerk News) Carl Zeiss is launching new systems for optical sectioning during the annual Society for Neuroscience’s Neuroscience 2009 meeting to be held in Chicago from October 17th to October 21st.
The ELYRA product family features several new superresolution microscopy methods and significantly expands the application of light microscopy by clearly resolving details which previously could not be imaged by commercially available systems. ELYRA’s high resolution and flexibility will allow scientists to expand their experimental design to enable study of cellular components smaller than the diffraction limit.
The new LSM 780 expands the LSM 7 laser scanning microscopy family. This new system has about double the sensitivity of existing laser scanning microscopes and allows the study of samples with very weak or quickly bleaching fluorescence signals. The improved sensitivity can also be used to collect images at higher speeds.
The third new product, VivaTome, is a new optical sectioning system created for developmental and cell biologists to examine the dynamics of living specimens. The VivaTome is easy to use and provides clear and quantifiable images of cell structures, tissue sections or living organisms.
With the launch of the new systems, ELYRA, LSM 780 and VivaTome, Carl Zeiss offers important new tools to allow scientists to expand their research horizons.
The Society for Neuroscience’s annual meeting is the largest scientific meeting of its kind and brings together leading scientists from around the world. Microscopy and Imaging are key enabling technologies for neuroscientists and help researchers to better understand causes of such diseases as Alzheimer‘s or epilepsy, so that one day therapies and cures can be developed.
Source: Carl Zeiss (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: